Jean-Guy Boiteau

USPTO Granted Patents = 34 (Patent Applications = 12)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 26 (Patent Applications = 33)

Average Co-Inventor Count = 2.9

ph-index = 4

Forward Citations = 119(Granted Patents)

Location History:

Saint-Aunes, FR (2004 - 2013)
Valbonne, FR (2011 - 2023)
Opio, FR (2019 - 2023)

Company Filing History:

25 out of 222

Galderma Research & Development

Centre National De La Recherche Scientifique

patents

5. 1 out of 29

Galderma Research & Development Snc

patents

where one patent can have more than one assignee

Years Active: 2004-2023

Loading Chart...

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11807726 - Method of crosslinking glycosaminoglycans (2023-11-07),

2. 11780970 - Carbohydrate crosslinker (2023-10-10),

3. 11643509 - Carbohydrate crosslinker (2023-05-09),

4. 11530301 - Carbohydrate crosslinker (2022-12-20),

5. 11214655 - Method of crosslinking glycosaminoglycans (2022-01-04),

6. 10988600 - Cyclodextrin-grafted cross-linked hyaluronic acid complexed with active drug substances and uses thereof (2021-04-27),

7. 10533061 - Grafting of cyclodextrin by amide bonds to an ether cross-linked hyaluronic acid and uses thereof (2020-01-14),

8. 10343999 - Method for synthesizing enantiomerically pure N-(pyridin-4-yl)-2-hydroxy-alkylamide derivatives (2019-07-09),

9. 10047172 - Single step functionalization and cross-linking of hyaluronic acid (2018-08-14),

10. 9908948 - Enantiopure or enantioenriched BDDE and its use as crosslinking agent in the manufacture of cross-linked products (2018-03-06),

11. 9745281 - Method for the synthesis of 4-(heterocycloalkyl)-benzene-1,3,-diol compounds (2017-08-29),

12. 9650337 - Method of synthesising 4-piperidin-4-yl-benzene-1,3-diol and the salts of same and novel compound tert-butyl 4-(2,4-dihydroxy-phenyl)-4-hydroxy-piperidine-1-carboxylate (2017-05-16),

13. 9580412 - Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases (2017-02-28),

14. 9526732 - Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies (2016-12-27),

15. 9415039 - Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases (2016-08-16),

Title: The Innovative Journey of Jean-Guy Boiteau

Introduction: Jean-Guy Boiteau, a visionary inventor hailing from Valbonne, France, has made significant contributions to the world of innovations with his creative mind and relentless pursuit of excellence.

Latest Patents: Boiteau's latest patents showcase his ingenuity in various fields, including technology, healthcare, and sustainable energy solutions. His inventions continue to push the boundaries of what is possible, inspiring others in the industry.

Career Highlights: Throughout his illustrious career, Boiteau has been recognized for his groundbreaking inventions that have revolutionized industries. His commitment to innovation and problem-solving has earned him a reputation as a trailblazer in the field of patents.

Collaborations: Boiteau has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has led to the successful development and commercialization of cutting-edge technologies.

Conclusion: Jean-Guy Boiteau's passion for innovation and his dedication to creating a positive impact on society through his inventions make him a true pioneer in the world of patents. His legacy will continue to inspire future generations of inventors to think outside the box and pursue their dreams relentlessly.

This text is generated by artificial intelligence and may not be accurate.